175 related articles for article (PubMed ID: 15609779)
1. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries.
Levine OS; Cherian T; Shah R; Batson A
J Health Popul Nutr; 2004 Sep; 22(3):268-74. PubMed ID: 15609779
[TBL] [Abstract][Full Text] [Related]
2. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
[TBL] [Abstract][Full Text] [Related]
3. Translational research to assist policy decisions about introducing new vaccines in developing countries.
Clemens JD; Jodar L
J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
[TBL] [Abstract][Full Text] [Related]
4. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
Mahoney RT; Krattiger A; Clemens JD; Curtiss R
Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
[TBL] [Abstract][Full Text] [Related]
5. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
Mahoney R
J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
[TBL] [Abstract][Full Text] [Related]
6. Seven-valent pneumococcal conjugate vaccines for developing countries.
Obaro S
Expert Rev Vaccines; 2009 Aug; 8(8):1051-61. PubMed ID: 19627187
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination in developing countries: where does science end and commerce begin?
Mathew JL
Vaccine; 2009 Jul; 27(32):4247-51. PubMed ID: 19389448
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
9. Paving the way for the introduction of new vaccines into developing countries.
Chabalgoity JA
Expert Rev Vaccines; 2005 Apr; 4(2):147-50. PubMed ID: 15889986
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
11. Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries.
Batson A; Meheus F; Brooke S
Vaccine; 2006 Aug; 24 Suppl 3():S3/219-25. PubMed ID: 16950010
[TBL] [Abstract][Full Text] [Related]
12. Developing countries roll out pneumococcal vaccine thanks to novel funding scheme.
Kmietowicz Z
BMJ; 2010 Dec; 341():c7230. PubMed ID: 21159770
[No Abstract] [Full Text] [Related]
13. Economic perspectives on the advance market commitment for pneumococcal vaccines.
Snyder CM; Begor W; Berndt ER
Health Aff (Millwood); 2011 Aug; 30(8):1508-17. PubMed ID: 21821567
[TBL] [Abstract][Full Text] [Related]
14. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.
Dinleyici EC; Yargic ZA
Expert Rev Vaccines; 2008 Nov; 7(9):1367-94. PubMed ID: 18980540
[TBL] [Abstract][Full Text] [Related]
16. [Pneumococcal infection-an evasive killer in developing countries].
Pedersen FK; Jensen L
Ugeskr Laeger; 2009 Mar; 171(13):1079. PubMed ID: 19321074
[No Abstract] [Full Text] [Related]
17. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
Grijalva CG; Edwards KM
Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
[No Abstract] [Full Text] [Related]
18. The costs of scaling up vaccination in the world's poorest countries.
Bishai D; McQuestion M; Chaudhry R; Wigton A
Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
[TBL] [Abstract][Full Text] [Related]
19. The role of television advertising in increasing pneumococcal vaccination coverage among the elderly, North Coast, New South Wales, 2006.
Wallace C; Corben P; Turahui J; Gilmour R
Aust N Z J Public Health; 2008 Oct; 32(5):467-70. PubMed ID: 18959552
[TBL] [Abstract][Full Text] [Related]
20. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
